NYSE · Personal Products & Services
CVSA (CVSA) Stock
$120.22
+3.78%
NYSE: CVSA
Consumer Cyclical
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
CVSA: Lowering target price to $122.00
Argus Research · Jul 22, 2026
Chamberlain University to Open Salt Lake City Campus; Now Accepting Applications for Fall 2026
Business Wire · Jul 21, 2026
Covista Earns Five National Honors Recognizing its Workplace Culture, Career Growth Opportunities and Commitment to Responsible Business
Business Wire · Jul 20, 2026
1 Profitable Stock to Own for Decades and 2 That Underwhelm
StockStory · Jul 14, 2026
Covista and the Covista Foundation Commit $10 Million and 50,000 Volunteer Hours to Build and Sustain the Healthcare Workforce
Business Wire · Jul 13, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held2.53%
Institutions Held103.75%
Institutions Float Held106.44%
Peer Comparison
About CVSA
CVSA stock trades at $120.22 with a market capitalization of $4.09B. The stock is valued at a price-to-earnings (P/E) ratio of 20.62, price-to-book of 2.97, price-to-sales of 2.23. Over the past 52 weeks the stock has ranged between $86.97 and $156.26, and currently trades 23.1% below its 52-week high.
On profitability, CVSA generates a return on equity (ROE) of 16.25%, above the typical market average, return on capital employed of 23.87%, an operating margin of 19.13%, a net profit margin of 12.26%.